https://regulatorynews.com/pembrolizumab-tmb-h-traditional-approval Regulatory News en 2026-10-23T10:48:10-04:00 FDA Narrows Pembrolizumab's TMB-High Cancer Approval https://regulatorynews.com/altay-therapeutics-dx5057-series-a Regulatory News en 2026-10-23T09:41:32-04:00 Altay Raises $37M for First Oral FSHD Drug https://regulatorynews.com/arrowhead-pharmaceuticals-redemplo-mhra-authorization Regulatory News en 2026-10-23T09:41:32-04:00 Arrowhead Wins UK Nod for Rare-Disease Drug Redemplo https://regulatorynews.com/neuroxt-next-cue-fda-clearance Regulatory News en 2026-10-23T09:41:32-04:00 NeuroXT Clears FDA for Alzheimer's Risk AI Tool https://regulatorynews.com/cardinal-health-presource-bd-alaris-early-alert Regulatory News en 2026-10-23T05:51:08-04:00 FDA Flags Recalled Infusion Sets in Cardinal Kits https://regulatorynews.com/fda-prescription-drug-software-guidance-final Regulatory News en 2026-10-23T05:51:08-04:00 FDA Finalizes Guidance on Drug Companion Apps https://regulatorynews.com/gsk-hibsago-bepirovirsen-hepatitis-b-approval Regulatory News en 2026-10-23T05:51:08-04:00 FDA Approves GSK's Hibsago for Chronic Hepatitis B https://regulatorynews.com/nouscom-series-d-nous-209-lynch-syndrome Regulatory News en 2026-10-22T10:03:48-04:00 Nouscom Raises $135M for Cancer-Prevention Vaccine https://regulatorynews.com/sab-biotherapeutics-sab-142-fast-track-t1d Regulatory News en 2026-10-22T10:03:48-04:00 SAB Bio Wins FDA Fast Track for Diabetes Drug https://regulatorynews.com/solventum-restrata-vac-therapy-510k-clearance Regulatory News en 2026-10-22T10:03:48-04:00 Solventum Clears FDA to Pair Two Wound Therapies https://regulatorynews.com/uk-ce-marking-indefinite-recognition Regulatory News en 2026-10-22T06:00:33-04:00 UK Confirms Indefinite Recognition of CE-Marked Devices